23 With the identification of a large number of genetic loci associated with human fat 24 distribution and its importance for metabolic health, the question arises as to what 25 the genetic drivers for discrete fat depot expansion might be. To date most studies 26 have focussed on conventional anthropometric measures such as waist-to-hip ratio 27 (WHR) adjusted for body mass index. We searched for genetic loci determining 28 discrete fat depots mass size using an exome-wide approach in 3 large cohorts.
Introduction
110 a Exome-wide significance was set to 2E -7 111 b The haplotype region is defined as the furthest 3' and 5' SNPs with a R 2 >0.9 with the index SNP 112 c SNP count is based on 1000 genome SNP data with SNPs in high LD (R 2 >0.9) with the index SNP 166 not reveal any suggestive eQTL (Fig 3C) either. This variant shows a large effect size and 167 is the first locus to be associated with arm fat mass (Arm fat =  -0.29, SD 0.043, p-168 value=1.5E -11 , Table 2 and Fig 1B) with an estimated per-allele effect size in the Oxford 169 Biobank (n=4,606) of 125g less arm fat mass (-5.8%, CI -9.3% to -2.3%) in men and 67g (-170 2.6%, CI -5.3% to 0.4%) in women (approximate fat mass (grams) per allele after adjusting 171 for covariates with % change in parentheses, Table S1 ). SPATA20, linked to 172 spermatogenesis in mice [24] , is highly expressed in human testes but also ubiquitously 173 expressed, including in adipose tissue. SPATA20 is a putative member of the thioredoxin 174 family and other members of this family have been shown to be involved in preadipocyte 175 proliferation[25] and pro-adipogenic Wnt signalling [26] . SPATA20 expression was higher 176 in men than women, although this was only significant for GSAT (p=0.01) (Fig S1) .
177 Expression of SPATA20 during adipocyte differentiation showed an increase between 178 days 0 to 7 of adipogenesis then a drop back to pre-differentiation levels between days 7
179 and 14 (p=8.3E -8 , Fig 2C) suggesting a role for this gene in adipocyte development.
180 Surprisingly, despite the arm-specific association, expression of SPATA20 was similar 181 between arm fat, ASAT and GSAT (Fig S2 A) . However, qPCR assessment of a number of 182 developmental genes (Homeobox genes) in arm fat compared to ASAT and GSAT showed 183 significant differences (Fig S2 B) indicating that arm fat is developmentally distinct from the 184 other fat depots assessed. It is therefore possible that SPATA20 is involved in an arm- 311 For this analysis we focussed on non-synonymous variants only, therefore all non-coding 312 variants and synonymous variants were filtered out post meta-analysis. The exome-wide 313 significant findings are presented in Fig 1 and S1 Table; the additional suggestive 314 significant findings are presented in S3 Table. 315 316 Additional informatics
317
For the three exome-wide significant loci the amino-acid substitutions was assessed 318 for functional significance using the predictSNP online consensus tool [15] 319 (https://loschmidt.chemi.muni.cz/predictsnp1/). This allows for assessment across a 320 number of different tools to generate a consensus assessment. For CCDC92 the S70C 321 missense variant was assessed; for UQCC1 the R51Q was assessed and for SPATA20 322 three different proteins as products of different splice variants were assessed (K422R, 323 K406R and K362R). 
328
Six genes found within the three index SNP LD boundaries (Table 2) were 329 assessed for expression levels across a collection of human adipose tissue gene 330 expression panels. Applied Biosystems Taqman assay-on-demand qPCR assays were 331 selected for each gene that also avoid the index SNPs presented here, for CCDC92 (ABI 332 assay, hs01556139), ZNF664 (ABI assay, hs00921074), DNAH10 (ABI assay, 333 hs1387352), SPATA20 (ABI assay, hs00256188), UQCC1 (ABI assay hs00921074) and 334 GDF5 (ABI assay, hs00167060).
335
336 For tissue panels, subcutaneous adipose tissue biopsies were collected by needle biopsy 337 as previously described [36] . For cell-cultured human primary preadipocytes, of both 338 abdominal subcutaneous fat (ASAT) and gluteofemoral fat (GSAT) origin, a differentiation 339 time course (n=6) was performed as described in Todorčević, et al. [37] . All biopsies and 340 cells were homogenized in Tri-reagent (cat. no. T9424, Sigma-Aldrich, UK) and RNA was 341 extracted with a standard Tri-reagent protocol. A total of 500ng RNA was used for cDNA 342 synthesis following standard protocols and random hexamer primers using the cDNA 372 Whilst we only consider non-synonymous variants in this analysis this does not discount 373 that the coding locus is also under the influence of an eQTL. To assess the available data 374 from resources such as the GTEx portal and to assess any eQTL effect between ASAT 375 and GSAT fat depots we used the combined resources available within the Oxford 376 Biobank.
377
378 Allele specific pPCR was run essentially as described in Fogarty et al.[39] .
379 Taqman genotyping assays (Applied Biosystems) were selected to fall within the 380 transcripts under investigation. For CCDC92 the index SNP assay performed poorly so the 381 Proxy SNP rs9863 (ABI assay, C_206415_30) was selected. To assess the nearby gene 382 ZNF664 a SNP in high LD with the CCDC92 index SNP that fell within the ZNF664 383 transcript, rs1054852 (ABI assay, C_1169873_10), was selected. For SPATA20 the index 384 SNP was used (rs62621401, ABI assay C_25983779_10) as was for UQCC1 (rs4911494, 385 ABI assay, C_25472999_10). As was previously stated neither DNAH10, nor GDF5 could 386 be detected in whole adipose tissue panels. Therefore, allele specific qPCR could not be 387 assessed for these two genes. 396 signals) between cDNA and gDNA any allelic expression differences observed in the 397 cDNA samples can be resolved. This is particularly relevant as technical variation exists 398 with each genotyping assay; particularly pronounced in SPATA20 (Fig 3C) . 424 marginal means were calculated (S1 Table) .
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